News
Why BioXcel Therapeutics Stock Flopped Again Today
Even though it's only Tuesday, BioXcel Therapeutics (NASDAQ: BTAI) is having a week to forget. After the biotech's share price tanked on Monday on the back of less-than-inspiring quarterly results
Why BioXcel Therapeutics Stock Flopped Again Today
Even though it's only Tuesday, BioXcel Therapeutics (NASDAQ: BTAI) is having a week to forget. After the biotech's share price tanked on Monday on the back of less-than-inspiring quarterly results
Why Rivian Stock Powered Higher Today
Rivian (NASDAQ: RIVN) stock is getting some attention from Wall Street today, and the market is taking note. Investors are driving shares of the electric pickup truck manufacturer into their
Why Rivian Stock Powered Higher Today
Rivian (NASDAQ: RIVN) stock is getting some attention from Wall Street today, and the market is taking note. Investors are driving shares of the electric pickup truck manufacturer into their
Why Rivian Stock Powered Higher Today
Rivian (NASDAQ: RIVN) stock is getting some attention from Wall Street today, and the market is taking note. Investors are driving shares of the electric pickup truck manufacturer into their
Why Rivian Stock Powered Higher Today
Rivian (NASDAQ: RIVN) stock is getting some attention from Wall Street today, and the market is taking note. Investors are driving shares of the electric pickup truck manufacturer into their
Why Rivian Stock Powered Higher Today
Rivian (NASDAQ: RIVN) stock is getting some attention from Wall Street today, and the market is taking note. Investors are driving shares of the electric pickup truck manufacturer into their
Why Rivian Stock Powered Higher Today
Rivian (NASDAQ: RIVN) stock is getting some attention from Wall Street today, and the market is taking note. Investors are driving shares of the electric pickup truck manufacturer into their
Why Shares of Rivian Hit a Pothole Today
Charged up about the electric truck maker's prospects, investors chose to park shares of Rivian (NASDAQ: RIVN) in their portfolios yesterday upon learning of management's interest in partnering with
Why Shares of Rivian Hit a Pothole Today
Charged up about the electric truck maker's prospects, investors chose to park shares of Rivian (NASDAQ: RIVN) in their portfolios yesterday upon learning of management's interest in partnering with
Why Shares of Rivian Hit a Pothole Today
Charged up about the electric truck maker's prospects, investors chose to park shares of Rivian (NASDAQ: RIVN) in their portfolios yesterday upon learning of management's interest in partnering with
Why Shares of Rivian Hit a Pothole Today
Charged up about the electric truck maker's prospects, investors chose to park shares of Rivian (NASDAQ: RIVN) in their portfolios yesterday upon learning of management's interest in partnering with
Why Shares of Rivian Hit a Pothole Today
Charged up about the electric truck maker's prospects, investors chose to park shares of Rivian (NASDAQ: RIVN) in their portfolios yesterday upon learning of management's interest in partnering with
Why Shares of Rivian Hit a Pothole Today
Charged up about the electric truck maker's prospects, investors chose to park shares of Rivian (NASDAQ: RIVN) in their portfolios yesterday upon learning of management's interest in partnering with
Why Shares of Arcutis Biotherapeutics Jumped This Week
Shares of Arcutis Biotherapeutics (NASDAQ: ARQT) climbed 21.2% for the week after rising as high as 23.8%, according to data provided by S&P Global Market Intelligence. The medical dermatology
Why Shares of Arcutis Biotherapeutics Jumped This Week
Shares of Arcutis Biotherapeutics (NASDAQ: ARQT) climbed 21.2% for the week after rising as high as 23.8%, according to data provided by S&P Global Market Intelligence. The medical dermatology
Why Shares of Arcutis Biotherapeutics Jumped This Week
Shares of Arcutis Biotherapeutics (NASDAQ: ARQT) climbed 21.2% for the week after rising as high as 23.8%, according to data provided by S&P Global Market Intelligence. The medical dermatology
Why Shares of Arcutis Biotherapeutics Jumped This Week
Shares of Arcutis Biotherapeutics (NASDAQ: ARQT) climbed 21.2% for the week after rising as high as 23.8%, according to data provided by S&P Global Market Intelligence. The medical dermatology
Why Shares of Arcutis Biotherapeutics Jumped This Week
Shares of Arcutis Biotherapeutics (NASDAQ: ARQT) climbed 21.2% for the week after rising as high as 23.8%, according to data provided by S&P Global Market Intelligence. The medical dermatology
Why Shares of Arcutis Biotherapeutics Jumped This Week
Shares of Arcutis Biotherapeutics (NASDAQ: ARQT) climbed 21.2% for the week after rising as high as 23.8%, according to data provided by S&P Global Market Intelligence. The medical dermatology
Mitsubishi UFJ Financial Group, Inc. Announces Filing of Annual Report on Form 20-F for the Year Ended March 31, 2023
Mitsubishi UFJ Financial Group, Inc. (NYSE:MUFG)(TOKYO:8306)(ISIN:JP3902900004)(MUFG) hereby announces that it has filed its Annual Report on Form 20-F for the fiscal year ended March 31, 2023 (the
Mitsubishi UFJ Financial Group, Inc. Announces Filing of Annual Report on Form 20-F for the Year Ended March 31, 2023
Mitsubishi UFJ Financial Group, Inc. (NYSE:MUFG)(TOKYO:8306)(ISIN:JP3902900004)(MUFG) hereby announces that it has filed its Annual Report on Form 20-F for the fiscal year ended March 31, 2023 (the
Mitsubishi UFJ Financial Group, Inc. Announces Filing of Annual Report on Form 20-F for the Year Ended March 31, 2023
Mitsubishi UFJ Financial Group, Inc. (NYSE:MUFG)(TOKYO:8306)(ISIN:JP3902900004)(MUFG) hereby announces that it has filed its Annual Report on Form 20-F for the fiscal year ended March 31, 2023 (the
Mitsubishi UFJ Financial Group, Inc. Announces Filing of Annual Report on Form 20-F for the Year Ended March 31, 2023
Mitsubishi UFJ Financial Group, Inc. (NYSE:MUFG)(TOKYO:8306)(ISIN:JP3902900004)(MUFG) hereby announces that it has filed its Annual Report on Form 20-F for the fiscal year ended March 31, 2023 (the
Mitsubishi UFJ Financial Group, Inc. Announces Filing of Annual Report on Form 20-F for the Year Ended March 31, 2023
Mitsubishi UFJ Financial Group, Inc. (NYSE:MUFG)(TOKYO:8306)(ISIN:JP3902900004)(MUFG) hereby announces that it has filed its Annual Report on Form 20-F for the fiscal year ended March 31, 2023 (the